Firms
Theme

CNK

Cinemark Holdings, Inc. · NYSE

News

18 latest

Zacks Investment Research

Cinemark Stock Gains 12% in a Month: Should You Buy, Hold or Sell?

Cinemark Holdings (CNK) stock rose 12.3% in the past month, outperforming the leisure industry decline of 3.3%. The theater operator benefited from record domestic summer box office results, premium-format expansion (XD, ScreenX, IMAX, D-BOX), growing merchandise sales, and strong loyalty program engagement. CNK trades at a discounted forward sales multiple of 1.21X versus the industry average of 2.37X, with improved 2026 and 2027 EPS estimates supporting a favorable investment outlook.

Zacks Investment Research

Cinemark (CNK) is an Incredible Growth Stock: 3 Reasons Why

Cinemark Holdings (CNK) has been highlighted as a compelling growth stock opportunity, earning a Zacks Growth Score of A and Zacks Rank #1 (Strong Buy). The company demonstrates strong fundamentals including projected EPS growth of 139.9% (versus 30.5% industry average), efficient asset utilization with an S/TA ratio of 0.76 (above the 0.65 industry average), and positive earnings estimate revisions with a 3.4% upward surge over the past month.

Zacks Investment Research

Best Momentum Stocks to Buy for October 14th

Zacks highlights three stocks with Rank #1 buy ratings and strong momentum: Nucor Corporation (steel manufacturing) with 8.6% three-month gains and 6.5% earnings estimate increase; Cinemark Holdings (cinema exhibition) with 29.5% three-month gains and 7.3% earnings estimate increase; and Medifast Inc (weight management) with 10.0% three-month gains and 47.2% earnings estimate increase.

Zacks Investment Research

Best Value Stocks to Buy for October 14th

Zacks highlights three stocks with Rank #1 buy ratings and strong value characteristics: American Integrity Insurance Group (AII) with a P/E of 7.10 and 15.1% earnings estimate increase, Nucor Corporation (NUE) in steel manufacturing with a P/E of 12.85 and 6.5% earnings increase, and Cinemark Holdings (CNK) in cinema exhibition with a P/E of 14.72 and 7.3% next-year earnings increase.

Zacks Investment Research

Cinemark Hits Record EBITDA: Is CNK's Margin Expansion Durable?

Cinemark Holdings achieved record adjusted EBITDA of $294 million and surpassed $1 billion in revenues for the first time, driven by strong box office results, premium formats, and higher per-capita spending. However, the company's margin expansion faces potential challenges from content mix volatility, release timing, and rising operational costs. Analysts believe the gains have a durable foundation but depend on consistent box office strength.

Zacks Investment Research

Earnings Estimates Moving Higher for Cinemark (CNK): Time to Buy?

Cinemark Holdings (CNK) has received a Zacks Rank #1 (Strong Buy) rating due to solid improvements in earnings estimates. The company is expected to earn $0.79 per share for the current quarter (+97.5% year-over-year) and $2.51 for the full year (+141.4% year-over-year). Analysts have raised estimates over the past month with no negative revisions, and the stock has gained 7.8% in the past four weeks.

Mentions CNK

Zacks Investment Research

MGM Resorts to Report Q3 Earnings: What's in Store for the Stock?

MGM Resorts is scheduled to report Q3 2026 earnings on Oct. 28 with consensus EPS expected to decline 45.8% to 13 cents from 24 cents year-ago, though revenues are projected to grow slightly by 0.1% to $4.25 billion. Strong group bookings and premium gaming demand in Las Vegas are expected to provide support, but softness in lower-end leisure demand and regional operations challenges may weigh on results. The company's Zacks model does not predict an earnings beat.

Zacks Investment Research

Zacks Investment Ideas feature highlights: CoreWeave, Cinemark, Oscar Health and Heico

Despite recent market volatility driven by AI concerns, rising rates, and geopolitical tensions, three stocks with strong Zacks Rank #1 ratings stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and Heico demonstrates consistent aerospace and defense sector strength. All three show improving earnings estimates and constructive technical setups independent of AI boom dependency.

Zacks Investment Research

3 Top Ranked Stocks Gaining Despite Market Turmoil

Amid market volatility triggered by rising interest rates, inflation concerns, and AI sector weakness, three stocks with strong earnings momentum stand out: Cinemark benefits from theater attendance recovery and pricing power, Oscar Health is transitioning to profitability with surging membership growth, and HEICO demonstrates consistent aerospace and defense sector strength. All three carry Zacks Rank #1 ratings and offer exposure outside the dominant AI investment theme.

Zacks Investment Research

AMC Stock Gains 20% in a Month: Should Investors Ride the Rally?

AMC Entertainment shares surged 20% in the past month, outperforming the leisure industry, driven by stronger moviegoing demand, higher per-patron spending, and effective cost controls. The company plans to add 150-250 premium auditoriums using third-party capital, expand its loyalty programs with over 40 million participants, and expects $100 million in movie-themed merchandise revenue in 2026.

Zacks Investment Research

Cinemark's Digital Marketing Push: Can It Strengthen Customer Loyalty?

Cinemark is expanding its digital marketing and personalization efforts to attract younger moviegoers and boost customer loyalty, leveraging its 40 million addressable customers for targeted promotions and social media campaigns. The company's stock has surged 45.1% over the past year, trading at a forward P/S multiple of 1.15 below industry average, with 2026 EPS estimates rising 141.4% year-over-year. However, sustained success depends on campaign resonance and film slate appeal.

The Motley Fool

AMC Stock Is in the Spotlight for All the Right Reasons. Here's Why It's a Buy Now.

AMC Entertainment has surged 86% in 2026 as domestic box office receipts reach their highest levels since 2019. Despite a challenging five-year track record and delayed profitability expectations until 2028, the company is benefiting from increased moviegoing, particularly among younger audiences. With strong loyalty programs and studio support, AMC could potentially double from current levels if it matches the operational efficiency of competitors like Cinemark and Marcus.

Zacks Investment Research

Can AMC's Loyalty Strategy Strengthen Customer Engagement and Visits?

AMC Entertainment is leveraging its AMC Stubs loyalty program, which has reached over 40 million U.S. households and represents more than 50% of the company's U.S. guest count in Q2 2026. The program provides AMC with direct access to customer preferences and viewing behavior, enabling more targeted marketing and repeat visit encouragement. AMC's stock has surged 118% over the past six months, significantly outperforming the industry average of 3.4%, though the company is expected to report a 77.1% year-over-year improvement in losses for 2026.

Zacks Investment Research

Zacks Industry Outlook Highlights News, Cinemark, IMAX and CuriosityStream

The Film and Television Production and Distribution industry is experiencing strong demand for digital entertainment, with companies benefiting from streaming trends. However, rising content costs and increased competition are pressuring profitability.

Zacks Investment Research

4 Film & Television Production Stocks to Watch on Solid Industry Trends

The Film and Television Production and Distribution industry is experiencing growth driven by increased digital entertainment demand, though rising content costs are pressuring profitability. The industry ranks in the top 12% of Zacks industries with positive earnings outlooks. Four stocks are highlighted: CuriosityStream (Strong Buy) with record Q2 results and AI licensing growth, IMAX (Buy) with record summer box office performance and network expansion, News Corporation (Hold) benefiting from AI content licensing partnerships, and Cinemark (Hold) supported by strong theatrical attendance and premium format expansion.

Zacks Investment Research

AMC Q2 EBITDA Jumps 70% as Theater Attendance Recovery Accelerates

AMC Entertainment reported strong Q2 results with attendance rising 13.5% to 71.3 million patrons and revenues increasing 14.2% to $1.597 billion. Adjusted EBITDA surged 69.6% to $321.4 million as operating costs grew only 4.1%, expanding margins to 20.1%. The company generated $190.1 million in free cash flow, though seasonal fluctuations remain a concern for full-year sustainability.

Zacks Investment Research

Is AMC Stock a Buy as Growth Improves and Leverage Remains Elevated?

AMC Entertainment is demonstrating improved operating performance with 2026 revenues projected to rise 14.6% and losses narrowing significantly. The company benefits from premium-format expansion and stronger per-guest spending. However, elevated leverage (6.5x vs. 3x target), ongoing equity dilution, and valuation above its five-year median present continued risks for investors.

Zacks Investment Research

AMC Stock Rises 13.6% in a Month: Can the Rally Keep Its Momentum?

AMC Entertainment reported strong Q2 2026 results with revenues up 14.2% and adjusted EBITDA jumping 69.6%, driven by 13.5% growth in global attendance. However, elevated leverage at 6.5x (above the 3x target) and shareholder dilution from equity financing remain concerns. While operational metrics support the recent 13.6% stock rally, sustained free cash flow generation and further balance sheet deleveraging are critical for durability.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CNK · 0 threads

Sign in to post on $CNK

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev